TRAW logo

Traws Pharma, Inc.

TRAW
Healthcare|Biotechnology|US
$0.22
+0.00 (+0.82%)
Cash / Share
$0.29

Ownership Breakdown

70.7%
Float
15.4M
Shares Outstanding
10.9M
Float Shares

Major Holders (20)

Combined: 154.5%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Orbimed Advisors LLCInvestment adviser11.90%1,876,198May 5, 202613D/G
OrbiMed Capital GP VIII LLCOther11.90%1,876,198May 5, 202613D/G
Sirenia Capital Management LPIA, PN9.90%6,565,474Aug 14, 202613D/G
Alex SilversteinHC, IN9.90%6,565,474Aug 14, 202613D/G
Alyeska Investment Group, L.P.Investment adviser9.90%302,252Feb 14, 202513D/G
Anand ParekhIndividual9.90%302,252Feb 14, 202513D/G
Alyeska Fund GP, LLCOther9.90%302,252Feb 14, 202513D/G
Perceptive Life Sciences Master Fund, LtdCorporation9.90%386,555Jan 8, 202513D/G
Ikarian Capital, LLCInvestment adviser9.50%1,555,423Aug 14, 202613D/G
Neil ShahrestaniHC, IN9.50%1,555,423Aug 14, 202613D/G
Chernett JoreyIndividual6.80%543,268Jan 16, 202613D/G
Joseph EdelmanIndividual6.10%979,815May 15, 202613D/G
Perceptive Life Sciences Master Fund, Ltd.Corporation6.10%979,815May 15, 202613D/G
Perceptive Advisors LLCInvestment adviser6.10%979,815May 15, 202613D/G
Robert AtchinsonHC, IN4.79%730,000Aug 12, 202613D/G
Adage Capital Management, L.P.IA, PN4.79%730,000Aug 12, 202613D/G
Phillip GrossHC, IN4.79%730,000Aug 12, 202613D/G
Alto Opportunity Master Fund, SPC - Segregated Master Portfolio BCorporation4.29%342,935Feb 11, 202613D/G
Ayrton Capital LLCIA, CO4.29%342,935Feb 11, 202613D/G
Waqas KhatriIndividual4.29%342,935Feb 11, 202613D/G

Insider Trades (100)

Last 4 quarters: 1,713,668 acquired · 704,142.745 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Pauza Charles DavidChief Science Officer VirologyJul 9, 2026AWARD97,000$0.68$66.0KForm 4
CAUTREELS WERNERdirectorJul 9, 2026AWARD14,150$0.68$9.6KForm 4
Savchuk Nikolaydirector, officer: Chief Operating OfficerJul 9, 2026AWARD93,000$0.68$63.2KForm 4
STOVER JACK EdirectorJul 9, 2026AWARD14,150$0.68$9.6KForm 4
Dukes Iain D.director, officer: Chief Executive OfficerJul 9, 2026AWARD274,000$0.68$186.3KForm 4
Redfield RobertChief Medical OfficerJul 9, 2026AWARD84,000$0.68$57.1KForm 4
Parker Charles NolanChief Financial OfficerJul 9, 2026AWARD90,000$0.68$61.2KForm 4
Shoemaker Mary TeresadirectorJul 9, 2026AWARD14,150$0.68$9.6KForm 4
Clarke TrafforddirectorJul 9, 2026AWARD14,150$0.68$9.6KForm 4
Leaman John HarolddirectorJul 9, 2026AWARD14,150$0.68$9.6KForm 4
ORBIMED ADVISORS LLC10 percent ownerApr 16, 2026BUY1,793,187$1.67$3.0MForm 4
ORBIMED ADVISORS LLC10 percent ownerApr 16, 2026BUY597,729$1.67$998.2KForm 4
ORBIMED ADVISORS LLC10 percent ownerApr 16, 2026BUY597,729$1.67$1.0MForm 4
ORBIMED ADVISORS LLC10 percent ownerApr 16, 2026BUY597,729$1.67$1.0MForm 4
Parker Charles NolanChief Financial OfficerMar 8, 2026AWARD104,544$1.60$167.3KForm 4
Parker Charles NolanChief Financial OfficerDec 12, 2025AWARD61,571$2.33$143.5KForm 4
Parker Charles NolanChief Financial OfficerOct 12, 2025AWARD32,406$3.01$97.5KForm 4
Parker Charles NolanChief Financial OfficerDec 12, 2025AWARD15,393——Form 4
Parker Charles NolanJul 3, 2025OTHER0——Form 4
Clarke TrafforddirectorMar 8, 2026AWARD33,435$1.60$53.5KForm 4
CAUTREELS WERNERdirectorMar 8, 2026AWARD31,258$1.60$50.0KForm 4
Leaman John HarolddirectorMar 8, 2026AWARD33,435$1.60$53.5KForm 4
Dukes Iain D.director, officer: Chief Executive OfficerMar 8, 2026AWARD231,336$1.60$370.1KForm 4
Pauza Charles DavidChief Science Officer VirologyMar 8, 2026AWARD118,367$1.60$189.4KForm 4
Savchuk Nikolaydirector, officer: Chief Operating OfficerMar 8, 2026AWARD96,899$1.60$155.0KForm 4
STOVER JACK EdirectorMar 8, 2026AWARD33,435$1.60$53.5KForm 4
Redfield RobertChief Medical OfficerMar 8, 2026AWARD108,854$1.60$174.2KForm 4
Shoemaker Mary TeresadirectorMar 8, 2026AWARD33,435$1.60$53.5KForm 4
Leaman John HarolddirectorDec 12, 2025AWARD16,234$2.33$37.8KForm 4
Leaman John HarolddirectorDec 12, 2025AWARD4,058——Form 4
Clarke TrafforddirectorDec 12, 2025AWARD24,629$2.33$57.4KForm 4
Clarke TrafforddirectorDec 12, 2025AWARD6,157——Form 4
CAUTREELS WERNERdirectorDec 12, 2025AWARD4,874——Form 4
CAUTREELS WERNERdirectorDec 12, 2025AWARD19,496$2.33$45.4KForm 4
Shoemaker Mary TeresadirectorDec 12, 2025AWARD24,629$2.33$57.4KForm 4
Shoemaker Mary TeresadirectorDec 12, 2025AWARD6,157——Form 4
STOVER JACK EdirectorDec 12, 2025AWARD24,629$2.33$57.4KForm 4
STOVER JACK EdirectorDec 12, 2025AWARD6,157——Form 4
Dukes Iain D.director, officer: Chief Executive OfficerDec 12, 2025AWARD36,943——Form 4
Dukes Iain D.director, officer: Chief Executive OfficerDec 12, 2025AWARD147,771$2.33$344.3KForm 4
Pauza Charles DavidChief Science Officer VirologyDec 12, 2025AWARD18,471——Form 4
Pauza Charles DavidChief Science Officer VirologyDec 12, 2025AWARD73,886$2.33$172.2KForm 4
Redfield RobertChief Medical OfficerDec 12, 2025AWARD16,419——Form 4
Redfield RobertChief Medical OfficerDec 12, 2025AWARD65,676$2.33$153.0KForm 4
Savchuk Nikolaydirector, officer: Chief Operating OfficerDec 12, 2025AWARD16,419——Form 4
Savchuk Nikolaydirector, officer: Chief Operating OfficerDec 12, 2025AWARD65,676$2.33$153.0KForm 4
Leaman John HarolddirectorNov 21, 2025AWARD12,770$2.31$29.5KForm 4
Savchuk Nikolaydirector, officer: Chief Operating OfficerOct 12, 2025AWARD22,435$3.01$67.5KForm 4
Redfield RobertChief Medical OfficerOct 12, 2025AWARD32,406$3.01$97.5KForm 4
Pauza Charles DavidChief Science Officer VirologyOct 12, 2025AWARD32,406$3.01$97.5KForm 4
Dukes Iain D.director, officer: Chief Executive OfficerOct 12, 2025AWARD64,839$3.01$195.2KForm 4
CAUTREELS WERNERdirectorOct 12, 2025AWARD11,530$3.01$34.7KForm 4
STOVER JACK EdirectorOct 12, 2025AWARD11,530$3.01$34.7KForm 4
Clarke TrafforddirectorOct 12, 2025AWARD11,530$3.01$34.7KForm 4
Shoemaker Mary TeresadirectorOct 12, 2025AWARD11,530$3.01$34.7KForm 4
Leaman John HarolddirectorOct 1, 2025AWARD15,609$1.89$29.5KForm 4
Leaman John HaroldOct 1, 2025OTHER0——Form 4
Clarke TrafforddirectorJun 19, 2025AWARD23,000$1.65$38.0KForm 4
STOVER JACK EdirectorJun 19, 2025AWARD23,000$1.65$38.0KForm 4
Shoemaker Mary TeresadirectorJun 19, 2025AWARD23,000$1.65$38.0KForm 4
CAUTREELS WERNERdirectorJun 19, 2025AWARD23,000$1.65$38.0KForm 4
TPAV, LLC10 percent ownerApr 2, 2025DISPOSED605,531——Form 4
TPAV, LLC10 percent ownerApr 2, 2025DISPOSED2,263.745——Form 4
CAUTREELS WERNERdirector, officer: Chief Executive OfficerFeb 18, 2025OPTION EX.96,348$0.01$963.48Form 4
CAUTREELS WERNERdirector, officer: Chief Executive OfficerFeb 18, 2025OPTION EX.96,348$0.01$963.48Form 4
Guerin Mark PatrickofficerFeb 5, 2025OTHER0——Form 4
Brennan NoraofficerFeb 5, 2025OTHER0——Form 4
ORBIMED ADVISORS LLC10 percent ownerDec 29, 2024BUY96,348$13.42$1.3MForm 4
ORBIMED ADVISORS LLC10 percent ownerDec 29, 2024BUY96,348$0.01$963.48Form 4
CAUTREELS WERNERdirector, officer: Chief Executive OfficerDec 29, 2024BUY96,348$13.42$1.3MForm 4
CAUTREELS WERNERdirector, officer: Chief Executive OfficerDec 29, 2024BUY96,348$0.01$963.48Form 4
TPAV, LLC10 percent ownerDec 29, 2024BUY96,348$0.01$963.48Form 4
TPAV, LLC10 percent ownerDec 29, 2024BUY96,348$13.42$1.3MForm 4
Savchuk Nikolaydirector, 10 percent owner, officer: Chief Operating OfficerDec 29, 2024BUY96,348$0.01$963.48Form 4
Savchuk Nikolaydirector, 10 percent owner, officer: Chief Operating OfficerDec 29, 2024BUY96,348$13.42$1.3MForm 4
ORBIMED ADVISORS LLC10 percent ownerSep 16, 2024OTHER0——Form 4
ORBIMED ADVISORS LLC10 percent ownerSep 16, 2024OTHER676,469——Form 4
Greenwood LubadirectorSep 16, 2024AWARD164,000$0.34$55.8KForm 4
Greenwood LubaSep 16, 2024OTHER0——Form 4
Guerin Mark PatrickCFOJun 10, 2024OPTION EX.5,500——Form 4
Guerin Mark PatrickCFOJun 18, 2024TAX W/H2,221$0.47$1.0KForm 4
Guerin Mark PatrickCFOJun 18, 2024OPTION EX.5,500——Form 4
ORBIMED ADVISORS LLCother: See RemarksApr 1, 2024OTHER0——Form 4
ORBIMED ADVISORS LLCother: See RemarksApr 1, 2024OTHER30,916,483——Form 4
ORBIMED ADVISORS LLCother: See RemarksApr 1, 2024OTHER0——Form 4
TPAV, LLC10 percent ownerApr 1, 2024DISPOSED0——Form 4
Viriom, Inc.10 percent ownerApr 3, 2024OTHER0——Form 4
Viriom, Inc.10 percent ownerApr 3, 2024OTHER48,011,144——Form 4
ORBIMED ADVISORS LLC10 percent ownerApr 1, 2024OTHER0——Form 4
TPAV, LLC10 percent ownerApr 1, 2024OTHER0——Form 4
TPAV, LLC10 percent ownerApr 1, 2024OTHER25,843,663——Form 4
Redfield RobertActing Chief Medical OfficerApr 1, 2024AWARD97,500$0.01$975.00Form 4
Pauza Charles DavidChief Science Officer VirologyApr 1, 2024AWARD503,227$0.01$5.0KForm 4
Pauza Charles DavidChief Science Officer VirologyApr 1, 2024AWARD333,136$0.07$23.3KForm 4
Pauza Charles DavidChief Science Officer VirologyApr 1, 2024AWARD97,500$0.01$975.00Form 4
CAUTREELS WERNERdirector, officer: Chief Executive OfficerApr 1, 2024AWARD200,000$0.01$2.0KForm 4
Savchuk Nikolaydirector, officer: Chief Operating OfficerApr 1, 2024AWARD3,802,890$0.07$266.2KForm 4
Savchuk Nikolaydirector, officer: Chief Operating OfficerApr 1, 2024AWARD1,645,100$0.01$16.5KForm 4
Savchuk Nikolaydirector, officer: Chief Operating OfficerApr 1, 2024AWARD885,532$0.01$8.9KForm 4
Savchuk Nikolaydirector, officer: Chief Operating OfficerApr 1, 2024AWARD67,550——Form 4